2nd Quarter - Report

KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.

Firm
Client
Income
$37,500
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

S. 639, the Preserve Access to Affordable Generics Act

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 639 (111th)

Health Issues HCR

S. 369, the Preserve Access to Affordable Generics Act H.R. 1427, the Promoting Innovation and Access to Life-Saving Medicine Act

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 369 (111th), H.R. 1427 (111th)

Copyright/Patent/Trademark CPT

S. 515, the Patent Reform Act of 2009

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 515 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.